ARCHIVES

FDA Proposes To Drop Specific Requirements For Reprint Distribution On Off-Label Uses.

This article is from The Cancer Letter archive.

Vol. 34 No. 07 | February 22, 2008

Download PDF Visit The Full Archive

Related Articles

October issue of Business & Regulatory Report included.

November 5, 2004

NCI Officials Open To Fine-Tuning Group Budgets As Advocates Chip Away At NCTN’s Façade

May 2, 2014

Zevalin Regimen Better Than Rituximab Alone For NHL

June 29, 2001

In Brief: Hospices Urges To Develop Program For AIDs Victims; Companies Give $25,5000 To NCI Fund

November 1, 1985

NCI Planning To Switch Drug Development Emphasis From Compound To Human Cancer Oriented Strategy

October 26, 1984

Congress Close to Approving Appropriations for FY 1985

September 14, 1984